State of the Art 2025 RD Report: Australia

1:1
This 2025 country report outlines the policy, research, care and support landscape for rare diseases in Australia.

This report gives an overview of rare disease activities in Australia in 2025, including the national action plan, research and funding, registration and biobanking, organisation of care, newborn screening, diagnostics, patient organisations, information resources, training and orphan medicinal products.

You might also be interested in

By connecting national priorities with European initiatives, NMGs support stronger coordination, knowledge exchange and alignment across the rare disease ecosystem.
At the “Advancement of Treatments for Rare Diseases” conference in Nicosia, European and national policymakers joined clinicians, researchers, regulators, industry representatives and patient advocates to examine how stronger coordination can translate scientific progress into better prevention, diagnosis, treatment and access to care for people living with rare diseases.
This 2025 country report outlines the policy, research, care and support landscape for rare diseases in Sweden.
Call text draft setting out rules, eligibility and staged application process for the ERDERA Clinical Trial Call 2026.